Rituximab and Omalizumab in Severe, Refractory Insulin Allergy

Patrick F. K. Yong, Rifat Malik, Sefina Arif, Mark Peakman, Stephanie Amiel, Mohammad A. A. Ibrahim, Andrew Gough

Research output: Contribution to journal › Letter › peer-review

38 Citations (Scopus)

Original language	English
Pages (from-to)	1045 - 1047
Number of pages	3
Journal	New England Journal of Medicine
Volume	360
Issue number	10
Publication status	Published - 5 Mar 2009

Cite this

@article{b38c968ee6804fb9beff9af59d92cafb,

title = "Rituximab and Omalizumab in Severe, Refractory Insulin Allergy",

author = "Yong, {Patrick F. K.} and Rifat Malik and Sefina Arif and Mark Peakman and Stephanie Amiel and Ibrahim, {Mohammad A. A.} and Andrew Gough",

year = "2009",

month = mar,

day = "5",

language = "English",

volume = "360",

pages = "1045 -- 1047",

journal = "New England Journal of Medicine",

issn = "1533-4406",

publisher = "Massachussetts Medical Society",

number = "10",

}

TY - JOUR

T1 - Rituximab and Omalizumab in Severe, Refractory Insulin Allergy

AU - Yong, Patrick F. K.

AU - Malik, Rifat

AU - Arif, Sefina

AU - Peakman, Mark

AU - Amiel, Stephanie

AU - Ibrahim, Mohammad A. A.

AU - Gough, Andrew

PY - 2009/3/5

Y1 - 2009/3/5

M3 - Letter

SN - 1533-4406

VL - 360

SP - 1045

EP - 1047

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 10

ER -